SavedAdd your journal

Journals / Bilimsel Tamamlayıcı Tıp Regülasyon ve Nöral Terapi Dergisi / 2026 / Cilt: 8 Sayı: 1

PERIODONTAL DISEASES

PERİODONTAL HASTALIKLAR

Tijen Secerli Dürer(Bilimsel Nöralterapi Derneği, İstanbul - Turkey)
Pages
34–37
Publication Date
2014-02-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This probiotic bacterias are and the antioxidant systems have enormous effect at the treatment

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Periodontitis is a bacterially induced, localized, chronic inflammatory disease.
📊
Key Findings & Data:Periodontal tissue destruction involves a complex chain of events.
💡
Conclusion & Impact:This probiotic bacterias are and the antioxidant systems have enormous effect at the treatment
🔬Design:Makale
📍Scope:Comprehensive Sample
⚙️Variables:Nöralterapi · lokal anestezik · periodontitis

Abstract

Periodontitis is a bacterially induced, localized, chronic inflammatory disease. Periodontal tissue destruction involves a complex chain of events. Bacterial stimulation, the release of inflammatory mediators and immunoglobulins, activation of phagocytes are part of this chain. Periodontal disease are shown that they can lead to a lot of systemic changes. For the formation of periodontal disease inflammation in the body has to be started. This probiotic bacterias are and the antioxidant systems have enormous effect at the treatment

Özet

Periodontitis bir bakteri infeksiyonu olarak başlayan, lokal, kronik inflamatuvar hastalıktır. Peridontal doku yıkımı kompleks bir olaylar zinciri içermektedir. Bakteriyel uyarımlar, inflamatuar mediatörlerin ve immunglobulinlerin salınımı, fagositlerin aktivasyonu bu zincirinin parçalarıdır. Periodontal hastalıkların bir çok sistemik değişikliğe yol açabilecekleri gösterilmiştir. Periodontal hastalığın oluşması için vücutta inflamasyonun başlamış olması gereklidir. Bu inflamasyonun tedavisinde probiotik bakterilerin ve antioksidan sistemlerin etkileri çok büyüktür.

🔖

Cite This Article

Dürer, T. S. (2014). PERIODONTAL DISEASES. Bilimsel Tamamlayıcı Tıp Regülasyon ve Nöral Terapi Dergisi, Cilt: 8 Sayı: 1, 34–37. https://ajindex.com/articles/1643217

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (20)

  1. AYDIN M., Oral Bakterilerde Aderans Tıp ve Dişhekimliğinde Genel ve Özel Mikrobiyoloji Güneş yayınevi. Ankara 2004 S:147-151
  2. BAŞTÜRK B., BOYACIOĞLU S. Mukozal İmmün Sistem: GALT, NALT VE BALT Güncel Gastroenteroloji, 9(2): 120-125
  3. BARRY M, ELEY W, STEPHEN W. Proteolytic and hydrolytic enzymes from putative periodontal pathogens: characteriztions, moleculer genetics, effects on host defenses and tissues and detection in gingival crevice fluid. Periodontol 2000 2003; 31: 105-124.
  4. BEKTAŞ M., ÖZDEN A. Barsak Florası Probiyotikler ve Karaciğer Hastalık- larında Probiyotiklerin Yeri, Güncel Gastroenteroloji 10(2);137-147
  5. CHAPPLE IL. Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Periodontol 1997;24(5):287-296.
  6. Consensus report. Periodontal diseases: pathogenesis and microbial fac- tors. Ann Periodontol 1996;1(1):926-932.
  7. COWLEY G.C, LEVİNE M. The effect of plaque ongingival epithelium. Oral Sci Rev 1972; 1: 103-127.
  8. Çanakçı CF, Çiçek Y, Çanakçı V. Reactive oxygen species and human inf- lammatory periodontal diseases. Biocem (Moscow) 2005; 70: 619-628.
  9. CUTLER CW, JOTWANİ R. Dendritic cells at the oral mucosal interface. J Dent Res. 2006;85:678–89.
  10. D’AİUTO F, GRAZİANİ F, TETE S, et al. Periodontitis: from local infec- tion to systemic diseases. Int J Immunopathol Pharmacol 2005;18(3 Suppl):1-11
  11. EBERSOLE JL, MACHEN RL, STEFFEN ML, WİLLMANN DE. Systemic acute phase reactants, C-reactive protein and haptoglobin, in adult periodon- titis. Clin Exp. Immunol 1997; 107;347-352
  12. GREGORY J, SEYMOUR GJ, Ford PJ et al: Infection or inflammation: The link between periodontal and cardiovascular diseases, Future Cardio- logy 2009;5(1):5-9.
  13. HAKANSSON A., MOLİN G., Gut Microbiota and Inflammation, Nutrients 2011, 3, 637-682;
  14. HALLİWELL B. How to characterize an antioxidant: an update. Biochem Soc Symp 1995;61:73-101.
  15. HEİNRİCH PC, CASTELL JV, ANDUS T. Interleukin-6 and the acute phase response. Biochem J 1990; 265;621- 636
  16. KALELİ İ., Probiyotiklerin Etki Mekanızması, ANKEM Derg 2007;21(Ek 2):238-242
  17. KIRSACLIĞLU CT., ÖZDEN A., Besin Allerjileri Güncel Gastroenteroloji 10(2);148- 158
  18. KOLL-KLAİS P, MÄNDAR R, LEİBUR E, MARCOTTE H, HAMMARSTRÖM L, MİKELSAAR M. Oral lactobacilli in chronic periodontitis and periodontal health: speciescomposition and antimicrobial activity. Oral Microbiol Immunol 2005; 20: 354-361.
  19. KRASSE P, CARLSSON B, DAHL C, PAULSSON A, NİLSSON A, SİNKİEWİCZ G. Decreased gum bleeding and reduced gingivitis by the probiotic Lac- tobacillus reuteri. Swed Dent J 2006; 30: 55-60.
  20. HAKANSSON A., MOLİN G., Gut Microbiota and Inflammation, Nutrients 2011, 3, 637-682;